US2020055883A1PendingUtilityA1

Cyclic di-nucleotides derivative for the treatment of cancer

58
Assignee: EISAI R&D MAN CO LTDPriority: Feb 17, 2017Filed: Feb 16, 2018Published: Feb 20, 2020
Est. expiryFeb 17, 2037(~10.6 yrs left)· nominal 20-yr term from priority
Inventors:Dae-Shik KimFrank FangAtsushi EndoHyeong Wook ChoiMing-Hong HaoXingfeng BaoKuan-Chun Huang
A61P 37/04A61K 31/7084C07H 21/00C07F 9/6587A61P 35/02C07H 21/02A61P 31/04C07B 2200/07A61P 35/00C07H 19/213A61P 35/04
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are compounds useful for the treatment of cancer.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A compound having the following formula:

Join the waitlist — get patent alerts

Track US2020055883A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.